Correct. As I stated there has to be discussions ongoing. You have either GlaxoSmithKline, Gilead which may want a piece of the HIV product. Then you have Pfizer and Merck that will want to get a hold of the patents possibly for CCR5 from Dr. Pestell. Then you also have the potential to license out the genetic testing product as well.